Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
It signals the pituitary gland to release a pulse of growth hormone
ELI LILLY'S ORAL GLP-1 THERAPY FOUNDAYO (ORFORGLIPRON) IS NOW AVAILABLE FOR WEIGHT LOSS Foundayo is the second oral GLP-1 drug approved for weight management Straight Healthcare April 2026 April 2026 The FDA recently approved Foundayo (orforglipron), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, for chronic weight management in adults
So before you jump into any new eating strategy, do the smart thing: get a thumbs-up from your doctor
Understanding this long-term perspective prevents unrealistic expectations about eventually stopping treatment
But if youre dealing with more significant weight loss goals or want extra support for muscle maintenance, then the higher dose of 2,000 mg might be a better fit
US$ 21.83
US$ 23.31
US$ 22.13
US$ 22.48
US$ 26.40
